U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5088150881Clinical Study of Peripheral Capillary Oxygen Saturation (SpO2): Vital Signs Patch (VSP)CompletedHas ResultsDesaturation of BloodDevice: Vital Signs Patch (VSP)https://ClinicalTrials.gov/show/NCT01899911
5088250882Efficacy of a Simplified Modified Atkins Diet in Children With Refractory EpilepsyActive, not recruitingNo Results AvailableRefractory EpilepsyOther: Simplified Modified Atkins Diet|Drug: Antiepileptic drugs alonehttps://ClinicalTrials.gov/show/NCT01899898
5088350883Acute High-risk Abdominal Surgery Study - an Optimized Perioperative CourseCompletedNo Results AvailablePerforated Viscus|Intestinal ObstructionProcedure: AHA (Acute Highrisk Abdominalsurgery): Optimized Coursehttps://ClinicalTrials.gov/show/NCT01899885
5088450884Effect of Acute Exercise on Endothelial Function in Patients With Type 1 Diabetes.RecruitingNo Results AvailableType 1 Diabetes MellitusBehavioral: Resistance exercise session|Behavioral: Aerobic exercise sessionhttps://ClinicalTrials.gov/show/NCT01899872
5088550885Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced FibrosisCompletedNo Results AvailableNon-Alcoholic Steatohepatitis (NASH)Drug: GR-MD-02|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01899859
5088650886Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in BloodCompletedNo Results AvailablePregnancyDrug: Hydroxyprogesterone caproate 250 mg/mlhttps://ClinicalTrials.gov/show/NCT01899846
5088750887Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)Enrolling by invitationNo Results AvailableCoronary Artery DiseaseRadiation: 99mTc-ECDGhttps://ClinicalTrials.gov/show/NCT01899833
5088850888Evaluation of the Efficacy of Artemisinin Combination Therapy in KenyaActive, not recruitingNo Results AvailableMalariaDrug: Artemether lumefantrine|Drug: Dihydroartemisinin piperaquinehttps://ClinicalTrials.gov/show/NCT01899820
5088950889Bone Reconstruction of the Skull Using a Metal Ceramic Implant After Previously Failed ReconstructionActive, not recruitingNo Results AvailableDefect of Skull Ossification|Other Specified Skull or Face Bone Anomaly|Cranial Dysostosis Nec|HemicraniectomyDevice: OssDsign ABhttps://ClinicalTrials.gov/show/NCT01899807
5089050890Efficacy of a Combined Surgical and Pharmacological Therapy to Treat Mixed Urinary Incontinence.CompletedNo Results AvailableUrinary Incontinence Mixed (Stress and Urge)Procedure: TVT-O/Oxytrol|Device: TVT-O|Drug: Oxytrolhttps://ClinicalTrials.gov/show/NCT01899794
5089150891Prophylactic Antibiotic Treatment for Hand Lacerations Involving Flexor and/or Extensor TendonNot yet recruitingNo Results AvailableHand Laceration|Tendon Involved|Clean Laceration|No Bone InvolvedDrug: Antibiotic-Cefamezinhttps://ClinicalTrials.gov/show/NCT01899781
5089250892GSK2339345 Hypertussive Challenge StudyCompletedNo Results AvailableCoughDrug: GSK2339345|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01899768
5089350893A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.CompletedNo Results AvailablePsoriasisDrug: GSK2800528, solution for injection|Drug: Placebo (0.9% w/v Sodium Chloride), solution for injection|Drug: Adalimumab, solution for injectionhttps://ClinicalTrials.gov/show/NCT01899755
5089450894The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have SympCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Umeclidinium/Vilanterol 62.5/25 mcg|Drug: Tiotropium 18 mcghttps://ClinicalTrials.gov/show/NCT01899742
5089550895A 12-week Dose-Ranging Trial in Patients With Moderate to Sever Plaque PsoriasisCompletedNo Results AvailablePlaque PsoriasisDrug: IMO-8400|Drug: IMO-8400|Drug: IMO-8400|Drug: Saline Placebohttps://ClinicalTrials.gov/show/NCT01899729
5089650896Exercise and Severe Depression: Clinical and Biological AnalysisCompletedNo Results AvailableDepressionOther: Exercisehttps://ClinicalTrials.gov/show/NCT01899716
5089750897A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of PruritusActive, not recruitingNo Results AvailableCholestasis, IntrahepaticDrug: GSK2330672|Drug: Placebo|Drug: Ursodeoxycholic acidhttps://ClinicalTrials.gov/show/NCT01899703
5089850898Antibiotics and Tissue Expanders in Breast ReconstructionNot yet recruitingNo Results AvailableComplications; Breast Prosthesis, Infection or InflammationDrug: antibiotichttps://ClinicalTrials.gov/show/NCT01899690
5089950899The Efficacy of Symbiotic on CytokinesCompletedHas ResultsNecrotising EnterocolitisOther: distilled water|Drug: symbiotichttps://ClinicalTrials.gov/show/NCT01899677
5090050900Upper Extremity Surgery in Spinal Cord InjuryRecruitingNo Results AvailableQuadriplegia|Spinal Cord Diseases|Spinal Cord InjuriesProcedure: Nerve Transfer Surgeryhttps://ClinicalTrials.gov/show/NCT01899664
5090150901Detection and Quantification of Neonatal Intraventricular HemorrhageEnrolling by invitationNo Results AvailableIntraventricular Brain Hemorrhagehttps://ClinicalTrials.gov/show/NCT01899651
5090250902Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study.CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: UMEC/VI 125/25 mcg|Drug: UMEC/VI 62.5/25 mcg|Drug: UMEC 125 mcg|Drug: UMEC 62.5 mcg|Drug: VI 25 mcghttps://ClinicalTrials.gov/show/NCT01899638
5090350903MI for Weight Loss With Young AdultsCompletedNo Results AvailableObesityBehavioral: Behavioral Weight Loss Intervention for Young Adults|Behavioral: Motivation Enhanced Behavioral Weight Losshttps://ClinicalTrials.gov/show/NCT01899625
5090450904Vaginal Inflammation Markers in Postmenopausal Women With and Without Symptoms of Vaginal InflammationCompletedNo Results AvailableMenopause|Vaginal Atrophyhttps://ClinicalTrials.gov/show/NCT01899612
5090550905PankoMab-GEXâ„¢ Versus Placebo as Maintenance Therapy in Advanced Ovarian CancerRecruitingNo Results AvailableOvarian Epithelial Cancer Recurrent|Fallopian Tube Cancer|Primary Peritoneal Cancer With High-grade (Grade 2 or 3) Serous Features or a Serous ComponentDrug: PankoMab-GEX|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01899599
5090650906Mechanisms and Functional Outcomes of Exercise Progression Models in the ElderlyCompletedNo Results AvailableElderly|SedentaryOther: Regional Specific Training Stimulus (RSTS)|Other: Aerobic Exercise Regimen (AE)https://ClinicalTrials.gov/show/NCT01899586
5090750907Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV FunctionRecruitingNo Results AvailableFunctional Mitral RegurgitationDevice: GDS Accucinch®https://ClinicalTrials.gov/show/NCT01899573
5090850908ELASTANCE: Prospective Physiological Study of Lung Elastance in Recruitment and Derecruitment in Early Onset Mechanically Ventilated ARDS PatientsCompletedNo Results AvailableAcute Respiratory Distress SyndromeProcedure: Measure lung and chest wall elastance with esophageal catheter|Other: non-invasive method for measuring the lung elastancehttps://ClinicalTrials.gov/show/NCT01899560
5090950909Laparoscopy-Assisted Surgery for Carcinoma of the Low RectumRecruitingNo Results AvailableRectal CarcinomaProcedure: laparoscopic-assisted rectal resection|Procedure: conventional open rectal resectionhttps://ClinicalTrials.gov/show/NCT01899547
5091050910Mental Health E-screening in Pregnant and Postpartum WomenCompletedNo Results AvailableDepression|AnxietyOther: E-screeninghttps://ClinicalTrials.gov/show/NCT01899534

* Görseller ve İçerik tekif hakkına sahip olabilir